Danny Altmann | |
---|---|
Academic background | |
Education | |
Academic work | |
Institutions | Imperial College London |
Danny Altmann is a British immunologist,and Professor of Immunology at Imperial College London. [1] [2]
Altmann earned a bachelor's degree from the University of London in 1980,and a PhD from the University of Bristol in 1983 on T cell immunity to herpesviruses. [3]
Altmann is the son of John Altmann, [4] who arrived as a refugee from the Holocaust on the Kindertransport, [5] and Marlene Altmann,who arrived after liberation from Auschwitz. Through her,he is in turn the great-grandson of German philanthropist Adolf Sternheim . [6]
Altmann runs a research lab at Imperial College's Hammersmith Hospital site,"focusing on HLA genes,T cells and NK cells in autoimmunity,cancer and infectious disease." [2] He has been based there since 1994. [7] Between 2011 and 2013 he was also Head of Pathogens,Immunity and Population Health at the Wellcome Trust. He now runs a suite of projects focussed on understanding the immunology of Long Covid, [8] which has included co-authoring The Long Covid Handbook. [9]
He is editor-in-chief of Oxford Open Immunology. [10] For 20 years,Altmann was editor of British Society for Immunology (BSI) journals,including 14-years as editor-in-chief at Immunology ,and is an associate editor at Vaccine and Frontiers in Immunology. [7] Altmann is a trustee of the Medical Research Foundation. [2] He has sat on the Strategy Board of the African Research Excellence Fund since its inception. [11]
During the COVID-19 pandemic,he has served in a number of policy advisory roles. [12] [13] He has been a member of Independent SAGE since December 2021. [14] He was the guest on the BBC Radio 4 programme The Life Scientific in February 2023. [15]
Sir Richard Brook Sykes is a British microbiologist,the chair of the Royal Institution,the UK Stem Cell Foundation,and the trustees at King Edward VII's Hospital,and chancellor of Brunel University. As of June 2021,he is chair of the UK's Vaccine Taskforce,where he is responsible for overseeing the delivery of the COVID-19 vaccination programme,including preparations for booster programmes and encouraging vaccine innovation in the UK.
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge,England. It has a portfolio of products for major diseases in areas including oncology,cardiovascular,gastrointestinal,infection,neuroscience,respiratory,and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Sir Leszek Krzysztof Borysiewicz is a British professor,immunologist and scientific administrator. He served as the 345th Vice-Chancellor of the University of Cambridge,his term of office started on 1 October 2010 and ended on 1 October 2017. Borysiewicz also served as chief executive of the Medical Research Council of the UK from 2007-2010 and was the chairman of Cancer Research UK from 2016 to 2023.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011,he was President of the United Kingdom's Academy of Medical Sciences,and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic,or necessary to elicit a protective immune response. Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression,in which case it is a recombinant subunit vaccine.
Sir Peter Julius Lachmann was a British immunologist,specialising in the study of the complement system. He was emeritus Sheila Joan Smith Professor of Immunology at the University of Cambridge,a fellow of Christ's College,Cambridge and honorary fellow of Trinity College,Cambridge and of Imperial College. He was knighted for service to medical science in 2002.
Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000. He is amongst the 0.01% most cited scientists of c. 7 million scientists in 22 major scientific fields globally.
Sir Gordon William Duff,is a British medical scientist and academic. He was principal of St Hilda's College,Oxford,from 2014 to 2021. He was Lord Florey Professor of Molecular Medicine at the University of Sheffield from 1991 to 2014.
Peter John Morland Openshaw,is a British clinician and scientist specialising in lung immunology,particularly defence against viral infections. He trained in lung diseases and undertook a PhD in immunology before establishing a laboratory at St Mary's Hospital Medical School. He created the academic department of Respiratory Medicine and the Centre for Respiratory Infection at Imperial College and was elected President of the British Society for Immunology in 2014.
Dame Sarah Catherine Gilbert FRS is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine,which underwent clinical trials in 2011.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),the virus that causes coronavirus disease 2019 (COVID‑19).
Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.
Rosemary Jane Boyton is a British immunologist who is Head of Lung Immunology and Adult Infectious Disease at Imperial College London. She works on the molecular immunology of infectious,allergic and autoimmune inflammation. She holds an honorary consultant position at the Royal Brompton Hospital,where she specialises in lung infection.
The Oxford–AstraZeneca COVID‑19 vaccine,sold under the brand names Covishield and Vaxzevria among others,is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca,using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that,for symptomatic COVID-19 infection after the second dose,the vaccine is 81% effective against the Alpha variant and 61% against the Delta variant.
Sir Andrew John Pollard is the Ashall Professor of Infection &Immunity at the University of Oxford and a Fellow of St Cross College,Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever,Neisseria meningitidis,Haemophilus influenzae type b,streptococcus pneumoniae,pertussis,influenza,rabies,and Ebola.
Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech,which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.
Özlem Türeci is a German physician,scientist and entrepreneur. In 2008,she co-founded the biotechnology company BioNTech,which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021,she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse,Uğur Şahin,have won a number of awards.
The MRC Weatherall Institute of Molecular Medicine at the University of Oxford is a research institute located at the John Radcliffe Hospital in Oxford. Founded in 1989 by Sir David Weatherall,the institute focuses on furthering our understanding of clinical medicine at a molecular level. It was one of the first institutes of its kind in the world to be dedicated to research in this area.
A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein,or antigen,to elicit an immune response. As of April 2021,six viral vector vaccines,four COVID-19 vaccines and two Ebola vaccines,have been authorized for use in humans.
In many countries a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science,religion,and law. These have included exaggerated claims about side effects,misrepresentations about how the immune system works and when and how COVID-19 vaccines are made,a story about COVID-19 being spread by 5G,and other false or distorted information. This misinformation,some created by anti-vaccination activists,has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize or coerce vaccination,such as lotteries,mandates,and free entry to events,which has in turn led to further misinformation about the legality and effect of these measures themselves.